Search research articles
Contact Us
Filters
Showing results (191-200 of 226) with videos related to
Page
of 23
Sort By:
Journal of Medicinal Chemistry
|
July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy
Kang Le, Michael J Soth, Jason B Cross, et al.
Journal of Medicinal Chemistry
|
June 11, 2015
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
Wylie S Palmer, Guillaume Poncet-Montange, Gang Liu, et al.
Epigenetics & Chromatin
|
September 24, 2015
Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery
Yanai Zhan, Maria Kost-Alimova, Xi Shi, et al.
RSC Medicinal Chemistry
|
September 19, 2025
Allosteric targeting of RIPK1: discovery of novel inhibitors <i>via</i> parallel virtual screening and structure-guided optimization
R S K Vijayan, Matthew M Hamilton, Dana E Pfaffinger, et al.
Cancer Research
|
July 4, 2015
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi, Thomas A Paul, Parantu K Shah, et al.
JAMA
|
June 24, 2005
Staphylococcus aureus endocarditis: a consequence of medical progress
Vance G Fowler, Jose M Miro, Bruno Hoen, et al.
Archives of Internal Medicine
|
March 11, 2009
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study
David R Murdoch, G Ralph Corey, Bruno Hoen, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2026
Structure-Guided Development of NRAS G12D Inhibitors Based on a 5‑Azaindole Core
Joshua B Cox, Vinay Nair, Pijus Mandal, et al.
Scientific Data
|
January 19, 2023
The global historical climate database HCLIM
Elin Lundstad, Yuri Brugnara, Duncan Pappert, et al.
Science Translational Medicine
|
May 10, 2019
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Liang Zhang, Yixin Yao, Shaojun Zhang, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 226) with videos related to
Sort By:
Page
of 23
Journal of Medicinal Chemistry
|
July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy
Kang Le, Michael J Soth, Jason B Cross, et al.
Journal of Medicinal Chemistry
|
June 11, 2015
Structure-Guided Design of IACS-9571, a Selective High-Affinity Dual TRIM24-BRPF1 Bromodomain Inhibitor
Wylie S Palmer, Guillaume Poncet-Montange, Gang Liu, et al.
Epigenetics & Chromatin
|
September 24, 2015
Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery
Yanai Zhan, Maria Kost-Alimova, Xi Shi, et al.
RSC Medicinal Chemistry
|
September 19, 2025
Allosteric targeting of RIPK1: discovery of novel inhibitors <i>via</i> parallel virtual screening and structure-guided optimization
R S K Vijayan, Matthew M Hamilton, Dana E Pfaffinger, et al.
Cancer Research
|
July 4, 2015
The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies
Bhavatarini Vangamudi, Thomas A Paul, Parantu K Shah, et al.
JAMA
|
June 24, 2005
Staphylococcus aureus endocarditis: a consequence of medical progress
Vance G Fowler, Jose M Miro, Bruno Hoen, et al.
Archives of Internal Medicine
|
March 11, 2009
Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study
David R Murdoch, G Ralph Corey, Bruno Hoen, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2026
Structure-Guided Development of NRAS G12D Inhibitors Based on a 5‑Azaindole Core
Joshua B Cox, Vinay Nair, Pijus Mandal, et al.
Scientific Data
|
January 19, 2023
The global historical climate database HCLIM
Elin Lundstad, Yuri Brugnara, Duncan Pappert, et al.
Science Translational Medicine
|
May 10, 2019
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Liang Zhang, Yixin Yao, Shaojun Zhang, et al.
Page
of 23